Express Healthcare
Home  »  News  »  Fortis Memorial Research Institute launches CATH LAB with ‘3D mapping Carto 7 machine’

Fortis Memorial Research Institute launches CATH LAB with ‘3D mapping Carto 7 machine’

0 111
Read Article

FMRI is the first and only hospital in India and South Asia to acquire the machine

Fortis Memorial Research Institute (Gurgaon) launched a CATH LAB with India’s first ‘3D Electro-Anatomical Mapping Carto 7 machine’. Fortis Memorial Research Institute is the first and only hospital in India and South Asia to acquire the advanced 3D mapping machine.

The launch event was organised under the aegis of Padma Bhushan Awardee, Dr TS Kler, Chairman, Fortis Heart & Vascular Institute, Fortis Memorial Research Institute, Gurugram and Fortis Hospital, Vasant Kunj and inaugurated by Rao Inderjit Singh, Minister of State (Independent Charge), Ministry of Statistics and Program Implementation, Government of India.

The ‘3D electro-anatomical mapping carto 7’ machine provides a comprehensive model of the entire heart, while simultaneously relaying information regarding the electrical activity (in the heart). The machine allows for the mapping of complex heart arrhythmias supporting electrophysiologists in making optimal treatment decisions.

Rao Inderjit Singh said, “I am very happy to be here with you all today. The commitment of Fortis Healthcare and Dr Kler has led me believe that there has been considerable foresight and investment behind the launch of India’s first 3D electro-anatomical mapping carto machine and the new state-of-the-art CATH Lab at this hospital. The efforts of the healthcare chain in ensuring that patients avail the most advanced cardiac treatment are commendable and I extend my thanks to the entire team on behalf of the Haryana and, particularly, Gurgaon residents. These initiatives are helping Gurgaon become a top healthcare and industrial hub in NCR region. I don’t hesitate to say that we have been able to do a lot in the field of healthcare due to the contribution of the private healthcare sector. Today it gives me great pride to say that Gurgaon is a leading centre for cardiac patients needing advanced facilities and treatment. I assure Fortis Memorial Research Institute of full cooperation from me and my team.”

Dr Ashutosh Raghuvanshi, Managing Director and CEO, Fortis Healthcare Limited said, “We are honored to have Shri Rao Inderjit Singh here with us today, at the inauguration of the Fortis Heart and Vascular Institute, a dedicated unit for cardiac care at our flagship hospital in Gurugram. I am extremely proud to announce the launch of our state-of-the-art CATH Lab with the 3D Electro-Anatomical Mapping Carto 7 machine. We are the first and only hospital in India and South Asia to acquire the 3D mapping Carto 7 machine, and as a leading healthcare provider in India, we constantly strive to ensure that the technology we employ in our service delivery remains at par with global standards. We will continue to innovate and bring efficiency into the healthcare space, and I am confident that the Fortis Heart and Vascular Institute will not only cater to the cardiac care needs of people from Delhi NCR, but also to those of international patients who visit India especially for treatment. I congratulate Dr Kler and his team on their success.”

Dr TS Kler said, “The recently acquired 3D electro-anatomical mapping carto 7 machine will allow us to map complex arrhythmias such as ventricular tachycardias and Atrial fibrillations. This will reduce mortality by enabling us to employ targeted interventions. There is an urgent need for such a machine because of the widespread prevalence of cardiac arrhythmias which are causing morbidities and resulting in hospitalizations. The 3D cardiac mapping system will prove to be vital in our work as it will reduce mapping time by offering information on the circuits and location of arrhythmias during the procedure. Fortis Heart and Vascular Institute also has developed latest non-surgical treatment for structural heart disease including TAVR, Mitraclip and tric valve. We are fully geared to do cardiac transplant and Artificial Heart for patients in need.”

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More
close-image